bioAffinity Technologies Inc (NASDAQ:BIAF) shares are trading higher on Wednesday. The move follows an announcement regarding a new clinical education initiative.
Physician Roundtable Series Announced
The company plans to host a live virtual physician roundtable on April 8. This event kicks off the “CyPath Lung in Practice” webinar series.
A panel of pulmonologists will discuss integrating the noninvasive CyPath Lung test into clinical practice. They will share real-world patient cases.
The focus remains on diagnosing indeterminate pulmonary nodules with greater certainty.
Enhancing Clinical Decision-Making
Participating physicians will demonstrate how the test guides clinical paths. Cases include identifying Stage 1A lung cancer.
The test also helps prevent “unnecessary invasive, risky and costly procedures,” according to …
This post was originally published here
